NCT00515723View on ClinicalTrials.gov

Glucose and Lipid Metabolism on Antipsychotic Medication

NACompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
SchizophreniaSchizoaffective DisorderType 2 Diabetes MellitusHyperglycemia
Interventions
DRUG

risperidone

randomized to 12 week trial of risperidone.

DRUG

olanzapine

randomized to 12 week trial of olanzapine.

DRUG

quetiapine

randomized to 12 week trial of quetiapine.

DRUG

ziprasidone

randomized to 12 week trial of ziprasidone.

Trial Locations (2)

63110

Washington Univeristy School of Medicine, St Louis

Washington University School of Medicine, Psychiatry Dept., St Louis

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Washington University School of Medicine

OTHER

NCT00515723 - Glucose and Lipid Metabolism on Antipsychotic Medication | Biotech Hunter | Biotech Hunter